Human pluripotent stem cells as tools for high-throughput and high-content screening in drug discovery

References

• Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40–51.
   PubMed Web of Science ®Google Scholar
• Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov. 2004;3(8):711–715.
   PubMed Web of Science ®Google Scholar
• Olson H, Betton G, Robinson D, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 2000;32(1):56–67.
   PubMed Web of Science ®Google Scholar
• Cook D, Brown D, Alexander R, et al. Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework. Nat Rev Drug Discov. 2014;13(6):419–431.
   PubMed Web of Science ®Google Scholar
• Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614–636.
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–1147.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872.
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917–1920.
   PubMed Web of Science ®Google Scholar
• Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132(4):661–680.
   PubMed Web of Science ®Google Scholar
• Barbaric I, Biga V, Gokhale PJ, et al. Time-lapse analysis of human embryonic stem cells reveals multiple bottlenecks restricting colony formation and their relief upon culture adaptation. Stem cell Reports. 2014;3(1):142–155.
   Web of Science ®Google Scholar
• Ohgushi M, Matsumura M, Eiraku M, et al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell. 2010;7(2):225–239.
   PubMed Web of Science ®Google Scholar
• Chen G, Hou Z, Gulbranson DR, Thomson JA. Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell. 2010;7(2):240–248.
   PubMed Web of Science ®Google Scholar
• Dumitru R, Gama V, Fagan BM, et al. Human embryonic stem cells have constitutively active Bax at the Golgi and are primed to undergo rapid apoptosis. Mol Cell. 2012;46(5):573–583.
   Web of Science ®Google Scholar
• Byrne AT, Southgate J, Brison DR, Leese HJ. Analysis of apoptosis in the preimplantation bovine embryo using TUNEL. J Reprod Fertil. 1999;117(1):97–105.
   Google Scholar
• Desmarais JA, Hoffmann MJ, Bingham G, Gagou ME, Meuth M, Andrews PW. Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress. Stem Cells. 2012;30(7):1385–1393.
   Web of Science ®Google Scholar
• International Stem Cell Initiative, Amps K, Andrews PW, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011;29(12):1132–1144.
   Web of Science ®Google Scholar
• Baker DE, Harrison NJ, Maltby E, et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol. 2007;25(2):207–215.
   PubMed Web of Science ®Google Scholar
• Draper JS, Smith K, Gokhale P, et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2004;22(1):53–54.
   PubMed Web of Science ®Google Scholar
• Enver T, Soneji S, Joshi C, et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet. 2005;14(21):3129–3140.
   PubMed Web of Science ®Google Scholar
• Avery S, Hirst AJ, Baker D, et al. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Reports. 2013;1(5):379–386.
   Web of Science ®Google Scholar
• Herszfeld D, Wolvetang E, Langton-Bunker E, et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol. 2006;24(3):351–357.
   Web of Science ®Google Scholar
• Fazeli A, Liew CG, Matin MM, et al. Altered patterns of differentiation in karyotypically abnormal human embryonic stem cells. Int J Dev Biol. 2011;55(2):175–180.
   Web of Science ®Google Scholar
• Werbowetski-Ogilvie TE, Bossé M, Stewart M, et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol. 2009;27(1):91–97.
   PubMed Web of Science ®Google Scholar
• Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol. 2000;227(2):271–278.
   PubMed Web of Science ®Google Scholar
• Vallier L, Alexander M, Pedersen RA. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci. 2005;118(pt 19):4495–4509.
   PubMed Web of Science ®Google Scholar
• Xu RH, Chen X, Li DS, et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol. 2002;20(12):1261–1264.
   PubMed Web of Science ®Google Scholar
• Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 2003;115(3):281–292.
   PubMed Web of Science ®Google Scholar
• Chen G, Gulbranson DR, Hou Z, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 2011;8(5):424–429.
   PubMed Web of Science ®Google Scholar
• Furue MK, Na J, Jackson JP, et al. Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci U S A. 2008;105(36):13409–13414.
   PubMed Web of Science ®Google Scholar
• Lu J, Hou R, Booth CJ, Yang SH, Snyder M. Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci U S A. 2006; 103(15):5688–5693.
   PubMed Web of Science ®Google Scholar
• Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, Thomson JA. Feeder-independent culture of human embryonic stem cells. Nat Methods. 2006;3(8):637–646.
   Web of Science ®Google Scholar
• Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005;2(3):185–190.
   PubMed Web of Science ®Google Scholar
• Rodin S, Antonsson L, Niaudet C, et al. Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat Commun. 2014;5:3195.
   PubMed Web of Science ®Google Scholar
• Amit M, Chebath J, Margulets V, et al. Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Rev. 2010;6(2):248–259.
   Web of Science ®Google Scholar
• Olmer R, Haase A, Merkert S, et al. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 2010;5(1):51–64.
   Web of Science ®Google Scholar
• Steiner D, Khaner H, Cohen M, et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat Biotechnol. 2010;28(4):361–364.
   Web of Science ®Google Scholar
• International Stem Cell Initiative, Adewumi O, Aflatoonian B, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 2007;25(7):803–816.
   Web of Science ®Google Scholar
• Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat. 2002;200(pt 3):249–258.
   PubMed Web of Science ®Google Scholar
• Tam PP, Behringer RR. Mouse gastrulation: the formation of a mammalian body plan. Mech Dev. 1997;68(1–2):3–25.
   PubMed Web of Science ®Google Scholar
• Kimelman D. Mesoderm induction: from caps to chips. Nat Rev Genet. 2006;7(5):360–372.
   Web of Science ®Google Scholar
• D’Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol. 2005;23(12):1534–1541.
   PubMed Web of Science ®Google Scholar
• Seguin CA, Draper JS, Nagy A, Rossant J. Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells. Cell Stem Cell. 2008;3(2):182–195.
   Web of Science ®Google Scholar
• Yu P, Pan G, Yu J, Thomson JA. FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. Cell Stem Cell. 2011;8(3):326–334.
   PubMed Web of Science ®Google Scholar
• Zhang P, Li J, Tan Z, et al. Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood. 2008;111(4):1933–1941.
   Web of Science ®Google Scholar
• Tada S, Era T, Furusawa C, et al. Characterization of mesendoderm: a diverging point of the definitive endoderm and mesoderm in embryonic stem cell differentiation culture. Development. 2005;132(19):4363–4374.
   PubMed Web of Science ®Google Scholar
• Davis RP, Ng ES, Costa M, et al. Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood. 2008;111(4):1876–1884.
   Web of Science ®Google Scholar
• Smith WC, Harland RM. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell. 1992;70(5):829–840.
   Web of Science ®Google Scholar
• Sasai Y, Lu B, Steinbeisser H, Geissert D, Gont LK, De Robertis EM. Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell. 1994;79(5):779–790.
   Web of Science ®Google Scholar
• Lee H, Shamy GA, Elkabetz Y, et al. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells. 2007;25(8):1931–1939.
   PubMed Web of Science ®Google Scholar
• Morizane A, Doi D, Kikuchi T, Nishimura K, Takahashi J. Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res. 2011;89(2):117–126.
   Web of Science ®Google Scholar
• Smith JR, Vallier L, Lupo G, Alexander M, Harris WA, Pedersen RA. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol. 2008;313(1):107–117.
   Web of Science ®Google Scholar
• Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009;27(3):275–280.
   PubMed Web of Science ®Google Scholar
• Itskovitz-Eldor J, Schuldiner M, Karsenti D, et al. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000;6(2):88–95.
   PubMed Web of Science ®Google Scholar
• Burridge PW, Anderson D, Priddle H, et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells. 2007;25(4):929–938.
   PubMed Web of Science ®Google Scholar
• Matsa E, Denning C. In vitro uses of human pluripotent stem cell-derived cardiomyocytes. J Cardiovasc Transl Res. 2012;5(5):581–592.
   Web of Science ®Google Scholar
• Denning C, Anderson D. Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity. Drug Discov Today Ther Strateg. 2009;5:223–232.
   Google Scholar
• Shirahashi H, Wu J, Yamamoto N, et al. Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage. Cell Transplant. 2004;13(3):197–211.
   Web of Science ®Google Scholar
• Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 2003;12(1):1–11.
   PubMed Web of Science ®Google Scholar
• Yang L, Soonpaa MH, Adler ED, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008;453(7194):524–528.
   PubMed Web of Science ®Google Scholar
• Graichen R, Xu X, Braam SR, et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation. 2008;76(4):357–370.
   Web of Science ®Google Scholar
• Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res. 2002;91(6):501–508.
   PubMed Web of Science ®Google Scholar
• D’Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006;24(11):1392–1401.
   PubMed Web of Science ®Google Scholar
• Jiang J, Au M, Lu K, et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells. 2007;25(8):1940–1953.
   PubMed Web of Science ®Google Scholar
• Fasano CA, Chambers SM, Lee G, Tomishima MJ, Studer L. Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell. 2010;6(4):336–347.
   PubMed Web of Science ®Google Scholar
• Perrier AL, Tabar V, Barberi T, et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A. 2004;101(34):12543–12548.
   PubMed Web of Science ®Google Scholar
• Li XJ, Du ZW, Zarnowska ED, et al. Specification of motoneurons from human embryonic stem cells. Nat Biotechnol. 2005;23(2):215–221.
   PubMed Web of Science ®Google Scholar
• Colman A, Dreesen O. Pluripotent stem cells and disease modeling. Cell Stem Cell. 2009;5(3):244–247.
   Web of Science ®Google Scholar
• Ebert AD, Yu J, Rose FF Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009;457(7227):277–280.
   PubMed Web of Science ®Google Scholar
• Yang YM, Gupta SK, Kim KJ, et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell. 2013;12(6):713–726.
   PubMed Web of Science ®Google Scholar
• Egawa N, Kitaoka S, Tsukita K, et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012;4(145):145ra104.
   PubMed Web of Science ®Google Scholar
• Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature. 1995;375(6534):754–760.
   PubMed Web of Science ®Google Scholar
• Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science. 1995;269(5226):973–977.
   PubMed Web of Science ®Google Scholar
• Yagi T, Ito D, Okada Y, et al. Modeling familial Alzheimer’s disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20(23):4530–4539.
   PubMed Web of Science ®Google Scholar
• Lee G, Papapetrou EP, Kim H, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature. 2009;461(7262):402–406.
   PubMed Web of Science ®Google Scholar
• Slaugenhaupt SA, Blumenfeld A, Gill SP, et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet. 2001;68(3):598–605.
   PubMed Web of Science ®Google Scholar
• Lee G, Ramirez CN, Kim H, et al. Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression. Nat Biotechnol. 2012;30(12):1244–1248.
   PubMed Web of Science ®Google Scholar
• Choi SM, Kim Y, Shim JS, et al. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology. 2013;57(6):2458–2468.
   PubMed Web of Science ®Google Scholar
• Akbarian S, Kim JJ, Potkin SG, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52(4):258–266.
   Web of Science ®Google Scholar
• Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 2000;57(3):237–245.
   PubMed Web of Science ®Google Scholar
• Volk D, Austin M, Pierri J, Sampson A, Lewis D. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry. 2001;158(2):256–265.
   Web of Science ®Google Scholar
• Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 2005;6(4):312–324.
   PubMed Web of Science ®Google Scholar
• Chiang CH, Su Y, Wen Z, et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry. 2011;16(4):358–360.
   PubMed Web of Science ®Google Scholar
• Carvajal-Vergara X, Sevilla A, D’Souza SL, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010;465(7299):808–812.
   PubMed Web of Science ®Google Scholar
• Sun N, Yazawa M, Liu J, et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med. 2012;4(130):130ra147.
   Web of Science ®Google Scholar
• Goldenberg I, Zareba W, Moss AJ. Long QT syndrome. Curr Probl Cardiol. 2008;33(11):629–694.
   Web of Science ®Google Scholar
• Itzhaki I, Maizels L, Huber I, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011;471(7337):225–229.
   PubMed Web of Science ®Google Scholar
• Soldner F, Laganière J, Cheng AW, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell. 2011;146(2):318–331.
   PubMed Web of Science ®Google Scholar
• Liu GH, Suzuki K, Qu J, et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell. 2011;8(6):688–694.
   PubMed Web of Science ®Google Scholar
• Grieshammer U, Shepard KA. Proceedings: consideration of genetics in the design of induced pluripotent stem cell-based models of complex disease. Stem Cells Transl Med. 2014;3(11):1253–1258.
   PubMed Web of Science ®Google Scholar
• Wise LD. The ICH S5(R2) guideline for the testing of medicinal agents. Methods Mol Biol. 2013;947:1–11.
   Google Scholar
• Daston GP. Genomics and developmental risk assessment. Birth Defects Res A Clin Mol Teratol. 2007;79(1):1–7.
   Google Scholar
• Hartung T. Toxicology for the twenty-first century. Nature. 2009; 460(7252):208–212.
   PubMed Web of Science ®Google Scholar
• Johnson EM, Dansky LA. A hydra assay as a pre-screen for teratogenic potential. Food Chem Toxicol. 1987;25(8):637–638.
   Google Scholar
• Moscona A. Rotation-mediated histogenetic aggregation of dissociated cells. A quantifiable approach to cell interactions in vitro. Exp Cell Res. 1961;22:455–475.
   PubMed Web of Science ®Google Scholar
• Pratt RM, Grove RI, Willis WD. Prescreening for environmental teratogens using cultured mesenchymal cells from the human embryonic palate. Teratog Carcinog Mutagen. 1982;2(3–4):313–318.
   Google Scholar
• Braun AG, Emerson DJ, Nichinson BB. Teratogenic drugs inhibit tumour cell attachment to lectin-coated surfaces. Nature. 1979; 282(5738):507–509.
   Web of Science ®Google Scholar
• Tickle C. Positional signalling by retinoic acid in the developing chick wing. Prog Clin Biol Res. 1983;110(pt A):89–98.
   Google Scholar
• Steele VE, Morrissey RE, Elmore EL, et al. Evaluation of two in vitro assays to screen for potential developmental toxicants. Fundam Appl Toxicol. 1988;11(4):673–684.
   Google Scholar
• Sadler TW, Horton WE, Warner CW. Whole embryo culture: a screening technique for teratogens? Teratog Carcinog Mutagen. 1982; 2(3–4):243–253.
   Google Scholar
• Van Maele-Fabry G, Delhaise F, Picard JJ. Morphogenesis and quantification of the development of post-implantation mouse embryos. Toxicol In Vitro. 1990;4(2):149–156.
   PubMed Web of Science ®Google Scholar
• Pitt JA, Carney EW. Development of a morphologically-based scoring system for postimplantation New Zealand White rabbit embryos. Teratology. 1999;59(2):88–101.
   Google Scholar
• Abbott BD, Harris MW, Birnbaum LS. Etiology of retinoic acid-induced cleft palate varies with the embryonic stage. Teratology. 1989;40(6):533–553.
   Google Scholar
• Kistler A. Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids. Arch Toxicol. 1987;60(6):403–414.
   PubMed Web of Science ®Google Scholar
• Gustafson AL, Stedman DB, Ball J, et al. Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay – progress report on phase I. Reprod Toxicol. 2012;33(2):155–164.
   Web of Science ®Google Scholar
• Ball JS, Stedman DB, Hillegass JM, et al. Fishing for teratogens: a consortium effort for a harmonized zebrafish developmental toxicology assay. Toxicol Sci. 2014;139(1):210–219.
   Web of Science ®Google Scholar
• Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol. 1985;87:27–45.
   PubMedGoogle Scholar
• Seiler AE, Buesen R, Visan A, Spielmann H. Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test. Methods Mol Biol. 2006;329:371–395.
   PubMedGoogle Scholar
• Barrier M, Jeffay S, Nichols HP, et al. Mouse embryonic stem cell adherent cell differentiation and cytotoxicity (ACDC) assay. Reprod Toxicol. 2011;31(4):383–391.
   Web of Science ®Google Scholar
• Genschow E, Spielmann H, Scholz G, et al. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern Lab Anim. 2002;30(2):151–176.
   PubMed Web of Science ®Google Scholar
• Genschow E, Spielmann H, Scholz G, et al. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim. 2004;32(3):209–244.
   Web of Science ®Google Scholar
• Adler S, Lindqvist J, Uddenberg K, Hyllner J, Strehl R. Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells. Altern Lab Anim. 2008;36(2):129–140.
   Web of Science ®Google Scholar
• Krug AK, Kolde R, Gaspar JA, et al. Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013;87(1):123–143.
   PubMed Web of Science ®Google Scholar
• Cezar GG. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs? Curr Opin Chem Biol. 2007;11(4):405–409.
   PubMed Web of Science ®Google Scholar
• West PR, Weir AM, Smith AM, Donley EL, Cezar GG. Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol Appl Pharmacol. 2010;247(1):18–27.
   PubMed Web of Science ®Google Scholar
• Munoz J, Low TY, Kok YJ, et al. The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Mol Syst Biol. 2011;7:550.
   PubMed Web of Science ®Google Scholar
• Panopoulos AD, Yanes O, Ruiz S, et al. The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res. 2012;22(1):168–177.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Liu E, Morrow DA, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 2005; 112(25):3868–3875.
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Reiter RJ, et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun. 1998;253(3):614–620.
   Web of Science ®Google Scholar
• Sundberg SA. High-throughput and ultra-high-throughput screening: solution – and cell-based approaches. Curr Opin Biotechnol. 2000; 11(1):47–53.
   PubMed Web of Science ®Google Scholar
• Altschuler SJ, Wu LF. Cellular heterogeneity: do differences make a difference? Cell. 2010;141(4):559–563.
   PubMed Web of Science ®Google Scholar
• Enver T, Pera M, Peterson C, Andrews PW. Stem cell states, fates, and the rules of attraction. Cell Stem Cell. 2009;4(5):387–397.
   Web of Science ®Google Scholar
• Niepel M, Spencer SL, Sorger PK. Non-genetic cell-to-cell variability and the consequences for pharmacology. Curr Opin Chem Biol. 2009;13(5–6):556–561.
   Web of Science ®Google Scholar
• Carpenter AE. Image-based chemical screening. Nat Chem Biol. 2007; 3(8):461–465.
   Web of Science ®Google Scholar
• Loo LH, Wu LF, Altschuler SJ. Image-based multivariate profiling of drug responses from single cells. Nat Methods. 2007;4(5):445–453.
   Web of Science ®Google Scholar
• Giuliano KA, Haskins JR, Taylor DL. Advances in high content screening for drug discovery. Assay Drug Dev Technol. 2003;1(4):565–577.
   PubMed Web of Science ®Google Scholar
• Taylor DL, Giuliano KA. Multiplexed high content screening assays create a systems cell biology approach to drug discovery. Drug Discov Today. 2005;Suppl:13–18.
   Google Scholar
• Desbordes SC, Placantonakis DG, Ciro A, et al. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell. 2008;2(6):602–612.
   Web of Science ®Google Scholar
• Andrews PD, Becroft M, Aspegren A, et al. High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules. Biochem J. 2010;432(1):21–33.
   Google Scholar
• Barbaric I, Gokhale PJ, Jones M, Glen A, Baker D, Andrews PW. Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies. Stem Cell Res. 2010;5(2):104–119.
   Web of Science ®Google Scholar
• Barbaric I, Gokhale PJ, Andrews PW. High-content screening of small compounds on human embryonic stem cells. Biochem Soc Trans. 2010;38(4):1046–1050.
   Google Scholar
• Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler SJ. Multidimensional drug profiling by automated microscopy. Science. 2004;306(5699):1194–1198.
   PubMed Web of Science ®Google Scholar
• Carragher NO. Profiling distinct mechanisms of tumour invasion for drug discovery: imaging adhesion, signalling and matrix turnover. Clin Exp Metastasis. 2009;26(4):381–397.
   Web of Science ®Google Scholar
• Danovi D, Falk A, Humphreys P, et al. Imaging-based chemical screens using normal and glioma-derived neural stem cells. Biochem Soc Trans. 2010;38(4):1067–1071.
   Google Scholar
• Eliceiri KW, Berthold MR, Goldberg IG, et al. Biological imaging software tools. Nat Methods. 2012;9(7):697–710.
   PubMed Web of Science ®Google Scholar
• Inoue H, Yamanaka S. The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther. 2011;89(5):655–661.
   PubMed Web of Science ®Google Scholar
• Miller JD, Ganat YM, Kishinevsky S, et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell. 2013;13(6):691–705.
   PubMed Web of Science ®Google Scholar
• Baker BM, Chen CS. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012;125(pt 13):3015–3024.
   PubMed Web of Science ®Google Scholar
• Nam KH, Smith AS, Lone S, Kwon S, Kim DH. Biomimetic 3D tissue models for advanced high-throughput drug screening. J Lab Autom. Epub 2014.
   Google Scholar
• Huh D, Hamilton GA, Ingber DE. From 3D cell culture to organs-on-chips. Trends Cell Biol. 2011;21(12):745–754.
   PubMed Web of Science ®Google Scholar